A diagnosis like this tends to bring mixed feelings. There may be relief in finally having a name for something you've been living with, and knowing that a structured treatment pathway exists. There can also be an adjustment period in coming to terms with a chronic condition and what managing it long-term looks like. Both are completely normal responses, and neither needs to be rushed.

What HS actually is and why it keeps getting missed

Hidradenitis suppurativa is a chronic inflammatory skin condition. It is not an infection or caused by poor hygiene. It is not something you brought on yourself.

HS affects the hair follicles in areas where skin rubs together, most commonly the armpits, groin, inner thighs, and under the breasts. In people with HS, those follicles become blocked and inflamed, leading to painful nodules, abscesses, and over time, scarring and tunnel-like tracts under the skin called sinus tracts. Because the lesions can look like boils or infected hair follicles, HS is frequently misidentified, sometimes for years.

What makes HS particularly easy to miss is that it's a systemic inflammatory condition, not just a skin problem. It shares biological pathways with other inflammatory diseases, and there are meaningful links between HS and inflammatory bowel disease, inflammatory arthritis, and metabolic syndrome. People with HS are more likely to have these conditions too, which is one reason specialist-led care matters. A dermatologist managing HS is looking at the whole picture, not just what's visible on the surface.

Why treatment is more complex than a cream or a course of antibiotics

Most HS patients have already discovered that antibiotics produce limited results. That's not a failure of the antibiotic. It's a reflection of what HS actually is. Because it's inflammatory rather than infectious, antibiotics can help manage secondary infection and have some anti-inflammatory effect, but they're not addressing the underlying disease.

Treatment for HS follows a stepped approach based on severity. For mild disease, topical and oral antibiotics, antiseptic washes, and careful wound management are often first-line. Hormonal therapies can help some patients. For moderate-to-severe HS, the treatment picture is more involved.

Two biologics are currently approved in Australia for moderate-to-severe HS: adalimumab (Humira) and secukinumab (Cosentyx). Both are available on the Pharmaceutical Benefits Scheme (PBS) under specific criteria and both require specialist oversight. They need PBS authority prescriptions, cold chain storage, and ongoing monitoring, which puts them in a different category to most medications dispensed at a community pharmacy.

What biologic therapy actually involves day to day

This is the part that often catches patients off guard, because it's rarely explained thoroughly at the specialist appointment.

Adalimumab is typically injected fortnightly. Secukinumab involves a loading phase with weekly injections before moving to a monthly maintenance schedule. Both are self-administered at home via pre-filled pen or syringe, which feels unfamiliar at first and becomes routine quickly for most people.

Accessing these medications through the PBS requires an authority prescription from your specialist, confirming that your HS meets the criteria for biologic therapy. Your pharmacist can help coordinate this process if you're not sure where to start.

Once you have the prescription, the medication needs to be stored in the fridge between 2°C and 8°C. That applies from the moment it leaves the pharmacy to the moment you use it. Before injecting, it's generally recommended to let the medication reach room temperature for around 15 to 30 minutes, as this reduces discomfort at the injection site. Beyond that window, it should go straight back in the fridge.

Ongoing monitoring typically involves regular check-ins with your dermatologist to assess treatment response, watch for side effects, and make adjustments if needed.

The pharmacy gap that exists

General pharmacies are built around volume and accessibility, which is exactly what most patients need. Biologics sit outside that model. They require dedicated cold storage, validated temperature-controlled delivery, and staff who understand the specific handling requirements of each medication. That's what specialty pharmacies are designed for.

In practice, that means your medication is stored correctly, packed with validated cold chain packaging for delivery, and dispensed by people who know what they're handling. It also means refill reminders before you run out, and a pharmacist you can contact with questions about your medication directly.

For patients who've spent years navigating a condition that was poorly understood, having that infrastructure in place makes a real difference.

How Ace can help

Ace works with dermatologists managing HS patients on biologic therapy. If you've recently been prescribed adalimumab or secukinumab for HS, we can help with PBS paperwork, cold chain delivery, refill reminders, and any questions that come up between specialist appointments. You don't need to figure out the logistics on your own.

You can learn more or join Ace at https://portal.acepharmacy.com.au. If you'd prefer to speak with someone directly, our team is available through the portal.

The information in this article is for general educational purposes only and does not constitute medical advice. Always consult your dermatologist, GP, or specialist for guidance specific to your condition and treatment.